75 related articles for article (PubMed ID: 21981550)
1. Effect of the β-propiolactone treatment on the adsorption and fusion of influenza A/Brisbane/59/2007 and A/New Caledonia/20/1999 virus H1N1 on a dimyristoylphosphatidylcholine/ganglioside GM3 mixed phospholipids monolayer at the air-water interface.
Desbat B; Lancelot E; Krell T; Nicolaï MC; Vogel F; Chevalier M; Ronzon F
Langmuir; 2011 Nov; 27(22):13675-83. PubMed ID: 21981550
[TBL] [Abstract][Full Text] [Related]
2. Treatment of influenza virus with beta-propiolactone alters viral membrane fusion.
Bonnafous P; Nicolaï MC; Taveau JC; Chevalier M; Barrière F; Medina J; Le Bihan O; Adam O; Ronzon F; Lambert O
Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):355-63. PubMed ID: 24140008
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the beta-propiolactone sensitivity and optimization of inactivation methods for human influenza H3N2 virus.
Sasaki Y; Yoshino N; Sato S; Muraki Y
J Virol Methods; 2016 Sep; 235():105-111. PubMed ID: 27142111
[TBL] [Abstract][Full Text] [Related]
4. Beta-Propiolactone Inactivation of Coxsackievirus A16 Induces Structural Alteration and Surface Modification of Viral Capsids.
Fan C; Ye X; Ku Z; Kong L; Liu Q; Xu C; Cong Y; Huang Z
J Virol; 2017 Apr; 91(8):. PubMed ID: 28148783
[TBL] [Abstract][Full Text] [Related]
5. Inactivated or damaged? Comparing the effect of inactivation methods on influenza virions to optimize vaccine production.
Herrera-Rodriguez J; Signorazzi A; Holtrop M; de Vries-Idema J; Huckriede A
Vaccine; 2019 Mar; 37(12):1630-1637. PubMed ID: 30765167
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of DNA by beta-propiolactone.
Perrin P; Morgeaux S
Biologicals; 1995 Sep; 23(3):207-11. PubMed ID: 8527119
[TBL] [Abstract][Full Text] [Related]
7. Genetic characterization of circulating seasonal Influenza A viruses (2005-2009) revealed introduction of oseltamivir resistant H1N1 strains during 2009 in eastern India.
Agrawal AS; Sarkar M; Ghosh S; Roy T; Chakrabarti S; Lal R; Mishra AC; Chadha MS; Chawla-Sarkar M
Infect Genet Evol; 2010 Dec; 10(8):1188-98. PubMed ID: 20678590
[TBL] [Abstract][Full Text] [Related]
8. Study of adsorption and penetration of E2(279-298) peptide into Langmuir phospholipid monolayers.
Larios C; Miñones J; Haro I; Alsina MA; Busquets MA; Trillo JM
J Phys Chem B; 2006 Nov; 110(46):23292-9. PubMed ID: 17107178
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of influenza virus hemagglutinin-mediated membrane fusion by a compound related to podocarpic acid.
Staschke KA; Hatch SD; Tang JC; Hornback WJ; Munroe JE; Colacino JM; Muesing MA
Virology; 1998 Sep; 248(2):264-74. PubMed ID: 9721235
[TBL] [Abstract][Full Text] [Related]
10. Sequential interaction of CD4 and HIV-1 gp120 with a reconstituted membrane patch of ganglioside GM3: implications for the role of glycolipids as potential HIV-1 fusion cofactors.
Hammache D; Yahi N; Piéroni G; Ariasi F; Tamalet C; Fantini J
Biochem Biophys Res Commun; 1998 May; 246(1):117-22. PubMed ID: 9600078
[TBL] [Abstract][Full Text] [Related]
11. The effect of chemical inactivation of bovine viral diarrhea virus with beta-propiolactone and binary ethyleneimine on plasma proteins and coagulation factors.
Refaie FM; Esmat AY; Mohamed AF; Mohamed WA
Egypt J Immunol; 2004; 11(2):9-20. PubMed ID: 16734113
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of African horse-sickness virus by betapropiolactone and by pH.
Parker J
Arch Virol; 1975; 47(4):357-65. PubMed ID: 237497
[TBL] [Abstract][Full Text] [Related]
13. Binding of influenza A virus to monosialoganglioside (GM3) reconstituted in glucosylceramide and sphingomyelin membranes.
Sato T; Serizawa T; Okahata Y
Biochim Biophys Acta; 1996 Nov; 1285(1):14-20. PubMed ID: 8948470
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of influenza-virus-induced cytopathy by sialylglycoconjugates.
Terabayashi T; Morita M; Ueno M; Nakamura T; Urashima T
Carbohydr Res; 2006 Sep; 341(13):2246-53. PubMed ID: 16854400
[TBL] [Abstract][Full Text] [Related]
15. Characterization of different strains of poliovirus and influenza virus by differential scanning calorimetry.
Krell T; Manin C; Nicolaï MC; Pierre-Justin C; Bérard Y; Brass O; Gérentes L; Leung-Tack P; Chevalier M
Biotechnol Appl Biochem; 2005 Jun; 41(Pt 3):241-6. PubMed ID: 15377284
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of SARS-CoV-2 by β-propiolactone causes aggregation of viral particles and loss of antigenic potential.
Gupta D; Parthasarathy H; Sah V; Tandel D; Vedagiri D; Reddy S; Harshan KH
Virus Res; 2021 Nov; 305():198555. PubMed ID: 34487766
[TBL] [Abstract][Full Text] [Related]
17. The role of target membrane sialic acid residues in the fusion activity of the influenza virus: the effect of two types of ganglioside on the kinetics of membrane merging.
Ramalho-Santos J; Pedroso De Lima MC
Cell Mol Biol Lett; 2004; 9(2):337-51. PubMed ID: 15213813
[TBL] [Abstract][Full Text] [Related]
18. A Langmuir monolayer study of the interaction of E1(145-162) hepatitis G virus peptide with phospholipid membranes.
Sánchez-Martín MJ; Haro I; Alsina MA; Busquets MA; Pujol M
J Phys Chem B; 2010 Jan; 114(1):448-56. PubMed ID: 20000622
[TBL] [Abstract][Full Text] [Related]
19. A strategy for selective, CD4+ T cell-independent activation of virus-specific memory B cells for limiting dilution analysis.
Li X; Vanitha DJ; Joo HM; He Y; Rouse BT; Sangster MY
J Immunol Methods; 2006 Jun; 313(1-2):110-8. PubMed ID: 16730022
[TBL] [Abstract][Full Text] [Related]
20. Activity of Melaleuca alternifolia (tea tree) oil on Influenza virus A/PR/8: study on the mechanism of action.
Garozzo A; Timpanaro R; Stivala A; Bisignano G; Castro A
Antiviral Res; 2011 Jan; 89(1):83-8. PubMed ID: 21095205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
